RADNET INC (RDNT)

US7504911022 - Common Stock

50.45  +1.95 (+4.02%)

After market: 50.45 0 (0%)

Fundamental Rating

4

Overall RDNT gets a fundamental rating of 4 out of 10. We evaluated RDNT against 117 industry peers in the Health Care Providers & Services industry. While RDNT is still in line with the averages on profitability rating, there are concerns on its financial health. RDNT is valued quite expensively, but it does show have an excellent growth rating.



5

1. Profitability

1.1 Basic Checks

RDNT had positive earnings in the past year.
RDNT had a positive operating cash flow in the past year.
Of the past 5 years RDNT 4 years were profitable.
Each year in the past 5 years RDNT had a positive operating cash flow.

1.2 Ratios

RDNT has a Return On Assets (0.11%) which is comparable to the rest of the industry.
With a decent Return On Equity value of 0.48%, RDNT is doing good in the industry, outperforming 62.07% of the companies in the same industry.
With a Return On Invested Capital value of 3.36%, RDNT perfoms like the industry average, outperforming 56.03% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for RDNT is significantly below the industry average of 8.60%.
The 3 year average ROIC (3.25%) for RDNT is below the current ROIC(3.36%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.11%
ROE 0.48%
ROIC 3.36%
ROA(3y)0.58%
ROA(5y)0.36%
ROE(3y)4.83%
ROE(5y)3.06%
ROIC(3y)3.25%
ROIC(5y)3.04%

1.3 Margins

With a Profit Margin value of 0.19%, RDNT perfoms like the industry average, outperforming 59.48% of the companies in the same industry.
RDNT's Profit Margin has declined in the last couple of years.
RDNT has a Operating Margin of 6.00%. This is in the better half of the industry: RDNT outperforms 72.41% of its industry peers.
RDNT's Operating Margin has improved in the last couple of years.
RDNT has a Gross Margin (21.66%) which is comparable to the rest of the industry.
RDNT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6%
PM (TTM) 0.19%
GM 21.66%
OM growth 3Y49.86%
OM growth 5Y11%
PM growth 3YN/A
PM growth 5Y-43.61%
GM growth 3Y2.03%
GM growth 5Y0.93%

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RDNT is destroying value.
RDNT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, RDNT has more shares outstanding
Compared to 1 year ago, RDNT has an improved debt to assets ratio.

2.2 Solvency

RDNT has an Altman-Z score of 1.78. This is a bad value and indicates that RDNT is not financially healthy and even has some risk of bankruptcy.
RDNT has a Altman-Z score (1.78) which is in line with its industry peers.
The Debt to FCF ratio of RDNT is 18.75, which is on the high side as it means it would take RDNT, 18.75 years of fcf income to pay off all of its debts.
RDNT has a Debt to FCF ratio of 18.75. This is comparable to the rest of the industry: RDNT outperforms 53.45% of its industry peers.
RDNT has a Debt/Equity ratio of 1.29. This is a high value indicating a heavy dependency on external financing.
RDNT's Debt to Equity ratio of 1.29 is on the low side compared to the rest of the industry. RDNT is outperformed by 63.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF 18.75
Altman-Z 1.78
ROIC/WACC0.39
WACC8.67%

2.3 Liquidity

A Current Ratio of 1.32 indicates that RDNT should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.32, RDNT is in line with its industry, outperforming 48.28% of the companies in the same industry.
A Quick Ratio of 1.32 indicates that RDNT should not have too much problems paying its short term obligations.
RDNT's Quick ratio of 1.32 is in line compared to the rest of the industry. RDNT outperforms 53.45% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 1.32

7

3. Growth

3.1 Past

RDNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 150.00%, which is quite impressive.
RDNT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.73% yearly.
RDNT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.05%.
Measured over the past years, RDNT shows a quite strong growth in Revenue. The Revenue has been growing by 10.64% on average per year.
EPS 1Y (TTM)150%
EPS 3YN/A
EPS 5Y2.73%
EPS growth Q2Q81.82%
Revenue 1Y (TTM)13.05%
Revenue growth 3Y14.68%
Revenue growth 5Y10.64%
Revenue growth Q2Q9.5%

3.2 Future

RDNT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.00% yearly.
RDNT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.49% yearly.
EPS Next Y12.2%
EPS Next 2Y23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.16%
Revenue Next 2Y8.49%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 100.90 indicates a quite expensive valuation of RDNT.
Compared to the rest of the industry, the Price/Earnings ratio of RDNT is on the same level as its industry peers.
RDNT is valuated expensively when we compare the Price/Earnings ratio to 24.55, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 89.93, the valuation of RDNT can be described as expensive.
RDNT's Price/Forward Earnings ratio is in line with the industry average.
RDNT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.92.
Industry RankSector Rank
PE 100.9
Fwd PE 89.93

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of RDNT is on the same level as its industry peers.
RDNT's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 83.42
EV/EBITDA 17.92

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as RDNT's earnings are expected to grow with 23.00% in the coming years.
PEG (NY)8.27
PEG (5Y)36.96
EPS Next 2Y23%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

RDNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

RADNET INC

NASDAQ:RDNT (5/1/2024, 4:24:32 PM)

After market: 50.45 0 (0%)

50.45

+1.95 (+4.02%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.69B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 100.9
Fwd PE 89.93
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)8.27
PEG (5Y)36.96
Profitability
Industry RankSector Rank
ROA 0.11%
ROE 0.48%
ROCE
ROIC
ROICexc
ROICexgc
OM 6%
PM (TTM) 0.19%
GM 21.66%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.32
Quick Ratio 1.32
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)150%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y12.2%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)13.05%
Revenue growth 3Y14.68%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y